ALDH1A1 and colorectal carcinoma: Several studies have been conducted to investigate co-factors to indirectly inhibit ALDH1, which have found that downregulation of either DCLK1, NEAT1, or KDM2B [81,91,92] not only inhibits ALDH1 expression in CRC but also alleviates invasion and chemoresistance.